Primary Unknown Squamous Cell Carcinoma with the Anaplastic Lymphoma Kinase Fusion Gene That Was Effectively Treated with Alectinib: A Case Report

Case Reports in Oncology · Published 2026-07-08 · DOI 10.1159/000552510

Free full text

Authors (7)

Keita Kawakado, Kentaro Tokumo, Tasuku Kato, Hirotoki Tsuda, Tomohiro Fujita, Yukihiro Ikuta, Takashi Yanagawa

Abstract

<p>Introduction: The anaplastic lymphoma kinase (ALK) fusion gene is expressed in 3%–5% patients with non-small cell lung cancer; targeting this gene with molecular targeted therapy results in a positive long-term prognosis. However, the ALK fusion gene expression rate is only 0.8% when restricted to pulmonary squamous cell carcinoma. Case Presentation: A 61-year-old non-smoking woman had undergone partial resection of the right lower lobe for lung adenocarcinoma 5 years previously, and ALK fusion gene positivity was confirmed at that time. Computed tomography (CT) revealed subcarinal lymph node enlargement. Subsequent positron emission tomography-CT imaging showed high uptake at this site and in the hepatic hilar lymph nodes. Subcarinal and hilar lymph node biopsies resulted in a diagnosis of squamous cell carcinoma. Squamous cell carcinoma of unknown primary was diagnosed because only metastatic lymph nodes were identified without a detectable primary lesion. Furthermore, the clinical presentation was considered inconsistent with metastatic recurrence, given the distinct histopathological difference from the initial surgical specimen and long disease-free interval. Treatment with carboplatin and paclitaxel was initiated. Although initial tumor reduction was achieved, the lesion subsequently progressed. After next-generation sequencing revealed ALK fusion gene positivity, the introduction of alectinib was effective. Conclusion: Alectinib is effective against ALK fusion gene-positive squamous cell carcinoma of unknown primary. </p>

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Citation

Kawakado, K., Tokumo, K., Kato, T., et al. (2026). Primary Unknown Squamous Cell Carcinoma with the Anaplastic Lymphoma Kinase Fusion Gene That Was Effectively Treated with Alectinib: A Case Report. Case Reports in Oncology. https://doi.org/10.1159/000552510

Related articles